Resources

/cancer-patients-prefer-decentralized-trials

How Decentralized Clinical Trials are Impacting Oncology Research

Clinical research is undergoing transformation across the board—but how will it impact oncology clinical trials? Science 37® has surveyed research executives at trial-sponsored…

Read Now

/Resources/how-decentralized-clinical-trials-are-impacting-oncology-research

Improving the Patient Journey & Increasing Equitable Access in Oncology Research

Accurate representations of patient populations are critical to producing reliable clinical evidence for patient care.

How Decentralized Clinical Trials Deliver on Diversity: A Case Study

/improving-patient-journey-increasing-equitable-access-oncology-research

Poster

Agile studies and fully Decentralized Clinical Trials are opening opportunities for any patient anywhere to benefit from participation in clinical research. This can have impacts on…

/Resources/how-decentralized-clinical-trials-deliver-diversity-case-study

Building Inclusive Clinical Trials for the LGBTQIA+ Community

As we consider the strides made in awareness and visibility through Pride Month, we look at our own arena, healthcare, and see a much different picture.

Read Now

/building-inclusive-clinical-trials-strategies-include-lgbtqia-community

Improve Long-Term Follow-Up Studies with DCT

The pandemic proved that decentralized clinical trials (DCTs) not only lower the burden of participation for patients, but can also help sponsors accelerate recruiting, increase…

/sites/default/files/2022-05/RWE_InsightBrief_d05.pdf

A New Era of Accessible Clinical Trials

The original clinical trial laid the foundation for modern clinical studies. Thanks to the people working in clinical research, we have the opportunity to provide access to more people…

/new-era-accessible-clinical-trials

A New Era of Accessible Clinical Trials

On this Clinical Trials Day, we highlight the opportunity to provide access to more people in more places and thank the people working within clinical research to make it happen.

/new-era-accessible-clinical-trials

Investing in our Mobile Nursing Network and Elevating our Nurses Voices.

This International Nurses Day we elevate the voices of our mobile nursing team and share what inspires them most about their work in decentralized clinical trials.

/investing-our-mobile-nursing-network-elevating-our-nurses-voices

New Diversity Reporting Imperatives For Clinical Trial Sponsors By Lawmakers & Regulators

The F.D.A. recommends that clinical trial sponsors develop a Race and Ethnicity Diversity Plan to inform outreach, recruitment and retention throughout the trial process.

/new-diversity-reporting-imperatives-clinical-trial-sponsors-lawmakers-regulators

Accelerate Enrollment and Enable Diversity with The Science 37 Metasite™

Traditional clinical trials exclude more than 90 percent of patients and providers because of geographic and access barriers. This leads to study delays, excessive costs, and…

Enable Faster, More Effective Trials with the Science 37 Operating System™

/Resources/accelerate-enrollment-and-enable-diversity-science-37-metasitetm

Brochure

Disjointed processes, disassociated technologies, and redundant oversight at multiple investigational sites lead to high costs and declining performance. Science 37’s Operating…

/Resources/science-37-operating-system-brochure

Mobile Nursing: A Global Mobile Healthcare Network

Mobile Nursing: A Global Mobile Healthcare Provider Network

The healthcare landscape has changed, and mobile healthcare is now an integral part of clinical research. Beyond nursing, mobile healthcare must deliver more – compassion,…

/Resources/mobile-nursing-global-mobile-healthcare-network

Decentralization: An Ethical Obligation

We have the capability to reach anyone, anywhere utilizing decentralized clinical trial techniques and more agile clinical trial designs.

For more than 60 years, the traditional clinical trial model has relied on a disparate network of independent investigator sites to find, enroll, and matriculate patients through a…

/sites/default/files/2022-04/S37_InsightBrief_DecentralizationAnEthicalObligation_r3.pdf

A New Clinical Leadership—The Agile Clinical Trial

To access the full advantage of decentralized trials, sponsors have to begin the planning process with agile in mind.

Pioneering a First-Of-It’s-Kind Decentralized Clinical Trial in Depression.

/new-clinical-leadership-agile-clinical-trial

Poster

For this Phase II study of an oral investigative compound, Science 37® embarked on a journey to design the first ever decentralized clinical trial (DCT) in depression.

There is a significant unmet medical need for patients with Major Depressive Disorder (MDD) who either do not respond to, or do not tolerate, current augmentation approaches for…

Benefits of DCT technology, mobile nursing and connected devices on pediatric clinical trials

/Resources/pioneering-first-its-kind-decentralized-clinical-trial-depression

Poster

Combining Decentralized Clinical Trial Technology, Effective Mobile Nursing and Connected Devices To Deliver Pediatric Clinical Trials At Home

At DIA Europe 2022, Senior Director of Nursing Solutions for Science 37, Brianne Peters presented a poster on Combining DCT Technology, Effective Mobile Nursing and Connected Devices…

/Resources/combining-dct-technology-effective-mobile-nursing-and-connected-devices-deliver-pediatric

Enhancing CNS Studies with Agile and Decentralized Clinical Trials

CNS clinical trials are among the fastest-growing adopters of decentralization.

/enhancing-cns-studies-agile-and-decentralized-clinical-trials

Breaking Through Mistrust to Better Mental Health in Black Communities

Can the future of ending health disparities and improving health outcomes for Black Americans be in participation in clinical trials? What role does mental health play in current and future health outcomes? A panel of experts discuss.

What role does mental health play in current and future health outcomes? A panel of experts discuss.

Decentralized Model Delivers in Major Depressive Disorder Clinical Trial

/breaking-through-mistrust-better-mental-health-black-communities

Case Study

A global leader in pharmaceuticals was looking to pilot the same interventional study in major depressive disorder (MDD) using a decentralized clinical trial (DCT) model to evaluate operational feasibility, data quality, enrollment speed, and retention. Science 37 helped expand reach beyond the confines of traditional sites, reaching patients who otherwise were unable to access the trial.

In parallel to their Phase IIb trial, a global leader in pharmaceuticals was looking to pilot the same interventional study in major depressive disorder (MDD) using a decentralized…

/Resources/decentralized-model-delivers-major-depressive-disorder-clinical-trial

Powering Rare Disease Research with Agile, Decentralized and Patient- Centric Approaches.

Clinical trials for rare diseases have always presented challenges. From investigator training to data collection, conducting clinical research for orphan disorders is mired with condition-specific challenges that slow development and place an enormous burden on patients wanting to participate in a potentially life-saving clinical trial.

Through the rapidly increasing trend of agile, patient-centric approaches, we can address the distinctive challenges for patients with rare diseases. Travel may be difficult. Many are…

/Resources/powering-rare-disease-research-agile-decentralized-and-patient-centric-approaches-0

Making Rare Disease Research Easier for Patients, Easier for Everyone

Through the rapidly increasing trend of agile, patient-centric approaches, we can address the distinctive challenges for patients with rare diseases. Travel may be difficult. Many are…

/Resources/making-rare-disease-research-easier-patients-easier-everyone

How Agile Clinical Trials are Impacting CNS Research

How will decentralization impact CNS (central nervous system) clinical trials? Science 37 has surveyed research executives at trial-sponsoring organizations, uncovering pivotal insights on how clinical research trends are impacting the CNS space.

We know that clinical research is undergoing transformation across the board—but how will it impact CNS (central nervous system) clinical trials? Science 37® has surveyed research…

RARECAST - Bringing the Trial to the Patient

/Resources/how-agile-clinical-trials-are-impacting-cns-research

Podcast

How is technology changing the types of data that can be gathered, and how is it reshaping clinical trials?

Listen now

https://globalgenes.org/rare-cast/episode-350/

Powering Rare Disease Research with Agile, Decentralized and Patient-Centric Approaches

Here are key takeaways from a recent Science 37-hosted rare disease-focused webinar:

/powering-rare-disease-research-agile-decentralized-and-patient-centric-approaches

Centralize Clinical Trials with Decentralized Clinical Trials.

As the industry adopts more agile and decentralized approaches, it has rallied around the term decentralized clinical trials and expanded its definition to include all mobile, remote,…

Are you prepared for the DEPICT Act? The industry is making significant headway in delivering diversity in clinical trials, and the time to do more is now.   On February 3, 2022, Rep…

/sites/default/files/2022-05/Decentralized_Clinical_Trials_Insight_Brief_d01.pdf

The DEPICT Act

/Resources/depict-act

Motivated by the Urgency for a Better Way: Researcher, Joannie Hayes’s Background Fuels Her Work and Reflection on Black History Month

/motivated-urgency-better-way-researcher-joannie-hayess-background-fuels-her-work-and-reflection

The Heart of a Researcher: Science-Centered Nortorious Coleman-Taylor Highlights the Importance of Black History Month

As a child Nortorious thought she wanted to be a doctor. While in school, however, she uncovered her true passion—research—studying science to help prevent people from avoiding poor health. Her heart as a researcher fuels her perspective about Black History Month and the importance of studying and honoring those who came before us as we work toward a better future.

/heart-researcher-science-centered-nortorious-coleman-taylor-highlights-importance-black-history

Building Trust – and the Bottom Line – by Future-Proofing Health With Innovation that is Truly Inclusive

Ryan Brown shares with us the details of a webinar hosted by Real Chemistry during the recent J.P. Morgan Conference on January 12. It focused on trust as it relates to diversity, equity and inclusion (DE&I) in the world of health, and the ways we can strive to reach the goal of being truly inclusive.

/building-trust-and-bottom-line-future-proofing-health-innovation-truly-inclusive

Reshaping Clinical Trials in 2022

learn more about reshaping trials in 2022, click here to download our latest report

/reshaping-clinical-trials-2022

Achieving Better Clinical Trial Outcomes by Strategically Targeting Neglected Patient Populations

As we kick off Black History Month, we reflect back on the recent Halloran Consulting Group Town Hall webinar and our discussion about achieving Diversity, Equity and Inclusion (DE&I) and breaking the boundaries that exist in our pursuit to procure bias-free clinical trial outcomes.

/achieving-better-clinical-trial-outcomes-strategically-targeting-neglected-patient-populations

Scientist Turned Advocate: Ryan Brown Shares Black History Month’s Dual Importance

Every February, Black History Month provides us a unique opportunity: It’s our chance to take pause and honor, recognize and celebrate the many past, present and underappreciated…

/scientist-turned-advocate-ryan-brown-shares-black-history-months-dual-importance

Privacy By Design Protects Clinical Trial Participants

Happy Data Privacy Day! But, really, isn’t every day privacy day? As Science 37’s Privacy Officer, I certainly take that approach. Protecting the privacy rights and freedoms of…

/privacy-design-protects-clinical-trial-participants

How Access to the HPV Vaccination is helping to Eliminate Cervical Cancer

With the arrival of Cervical Health Awareness Month, comes news out of the U.K. that The human papillomavirus, or HPV, the vaccine is cutting cases of cervical cancer by nearly 90%.

/how-access-hpv-vaccination-helping-eliminate-cervical-cancer

Working with Native Americans to Navigate the COVID-19 Crisis

This Native American Heritage Month, we take a look at how the COVID-19 crisis has highlighted long standing inequities, as well as the fight to overcome them.

/Resources/Working-with-Native-Americans-to-Navigate

The Clinical Trial of the Future Survey Report

New data suggests we are approaching a milestone on the tech-enabled path to a patient-focused future.

Enabling Diversity in Cancer Screening Study

/Agile-Clinical-Trial-Report

Case Study

We take a bespoke approach to all our trials. We understand every therapeutic area is different. We performed a careful review of trial design, inclusion/exclusion criteria, and review…

Ensuring Diversity in a COVID-19 study

/Resources/enabling-diversity-cancer-screening-study

Case Study

We take a bespoke approach to all our trials. We understand every therapeutic area is different. We perform careful review of trial design, inclusion/exclusion criteria, and review of…

/Resources/ensuring-diversity-covid-19-study

The Decentralized Clinical Trial Operating System

A requisite, technology-first platform with limitless configurations to enable clinical research.

Clinical Research in the COVID-19 Era: Methods for Continuity

/DCT-OS-Report

White Paper

Adjust ongoing trials and have the changes expeditiously reviewed by an accredited IRB.

/Covid-19

Empowering Diversity in Clinical Trials

Diverse audiences want to participate in clinical trials but so often, are not asked, overlooked, or unable to access because of geographic barriers. The Diversity in Clinical Trials…

Navigating Clinical Trials in the Coronavirus Era

/Resources/empowering-diversity-clinical-trials

White Paper

Explore approaches to mitigate risks to patient safety in ongoing clinical trials.